UNCY Earnings

Quarterly EPS
$-0.46
Q3 2024
$-0.98
Q4 2024
$0.04
Q1 2025
$-0.52
Q2 2025
$-0.33
Q3 2025
$-0.68
Q4 2025
$-0.54
Q1 2026
$-0.06
Q2 2026
Latest RevenueN/A
Latest Net Income-1722000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.060-1722000—+88.5%
Q1 2026-$0.540-12823000—-1,450.0%
Q4 2025-$0.680-14668000—+30.6%
Q3 2025-$0.330-6011000—+28.3%
Q2 2025-$0.520-6447000—-165.0%
Q1 2025$0.040570.0K—+100.7%
Q4 2024-$0.980-21525000—+55.9%
Q3 2024-$0.460-4096000—+64.6%
Q2 2024$0.8009.9M——
Q1 2024-$6.100-20963000——
Q4 2023-$2.220-7798000——
Q3 2023-$1.300-4333000——
Unicycive Therapeutics (UNCY) — Earnings